Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use as health supplements and medications. Further, it is developing 3F (functional fragrance formulation), a formulation of botanical ingredients. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. Impact BioMedical Inc. operates as a subsidiary of DSS BioHealth Security, Inc
Часто задаваемые вопросы
В каком секторе работает Impact BioMedical, Inc. (IBO)?
Impact BioMedical, Inc. относится к сектору Здравоохранение.
Какова текущая цена акций Impact BioMedical, Inc. (IBO)?
По последним данным, цена акций Impact BioMedical, Inc. составляет 3,73 $, предыдущее закрытие — 3,60 $. За последнюю торговую сессию акции Impact BioMedical, Inc. выросли на 0,13 $, что соответствует росту на 3,61%.
Какой коэффициент цена/прибыль (P/E) компании Impact BioMedical, Inc. (IBO)?
Текущий коэффициент P/E компании Impact BioMedical, Inc. составляет 4,24.
Выплачивает ли Impact BioMedical, Inc. (IBO) дивиденды?
Нет, Impact BioMedical, Inc. не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Impact BioMedical, Inc. (IBO)?
У компании Impact BioMedical, Inc. бета 0.207, что указывает на более низкую волатильность по сравнению с рынком в целом.
